Supplemental material
Pathogens and Global Health
Volume 112, 2018 - Issue 8
Original Articles
Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the Vizient Health Systems Data from 2011 to 2017
, 
, &
Mark P. ConnollyDepartment of Pharmacy, Unit of Pharmacoepidemiology & Pharmacoeconomics, University of Groningen, Groningen, The Netherlands;Global Market Access Solutions LLC, Mooresville, NC, USACorrespondence[email protected] [email protected]
http://orcid.org/0000-0002-1886-745XView further author information
http://orcid.org/0000-0002-1886-745XView further author information, & Ruben R. Ben-HarariDepartment of Medical Affairs, Vyera Pharmaceuticals, New York, NY, USAhttp://orcid.org/0000-0001-6531-2409View further author information
http://orcid.org/0000-0001-6531-2409View further author informationRelated Research Data
Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the Vizient Health Systems Data from 2011 to 2017
Source:
Figshare
Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the Vizient Health Systems Data from 2011 to 2017
Source:
Taylor & Francis
Linking provided by
